Selank

As research shows

Selank is a synthetic heptapeptide analog of tuftsin with demonstrated anxiolytic and anti-asthenic (energy-boosting) properties in human clinical trials. In Russian studies, intranasal Selank produced anxiolytic effects comparable to benzodiazepines without sedation or dependence potential. This educational protocol presents a once‑daily subcutaneous approach using practical dilution for accurate insulin‑syringe measurements.

Key benefits

• * Produces anxiolytic effects comparable to benzodiazepines in human clinical trials without sedation or dependence risk
• Provides anti-asthenic (energy-boosting) benefits alongside anxiety reduction
• * Induces lasting neurobehavioral changes; primate studies showed elimination of fear/anxiety behaviors with long-term stabilizing effects